XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Note 1 - Nature of Activities and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Disaggregation of Revenue [Table Text Block]
  

For the three months ended September 30,

  

For the nine months ended September 30,

 
  

2023

  

2022

  

2023

  

2022

 

Ethanol sales

 $36,375  $44,673  $45,388  $130,224 

Wet distillers grains sales

  9,427   13,003   11,980   39,669 

Other sales

  1,637   3,232   1,878   8,947 

Total

 $47,439  $60,908  $59,246  $178,840 
  

For the three months ended September 30,

  

For the nine months ended September 30,

 
  

2023

  

2022

  

2023

  

2022

 

Biodiesel sales

 $19,291  $10,828  $53,292  $10,828 

Other sales

  853   95   1,892   113 

Total

 $20,144  $10,923  $55,184  $10,941 
Schedule of Cash and Cash Equivalents [Table Text Block]
  

As of

 
  

September 30, 2023

  

December 31, 2022

 

Cash and cash equivalents

 $3,899  $4,313 

Restricted cash included in other current assets

  401   725 

Restricted cash included in other assets

  3,365   1,961 

Total cash, cash equivalents, and restricted cash shown in the statement of cash flows

 $7,665  $6,999 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
  

For the three months ended September 30,

 

For the nine months ended September 30,

  

2023

 

2022

 

2023

 

2022

Net income (loss)

 

$ 30,711

 

$ (66,845)

 

$ (20,978)

 

$ (85,348)

Shares:

        

Weighted average shares outstanding—basic

 

38,881

 

34,769

 

37,504

 

34,344

         

Weighted average dilutive share equivalents from preferred shares

 

126

 

-

 

-

 

-

Weighted average dilutive share equivalents from stock options

 

2,808

 

-

 

-

 

-

Weighted average dilutive share equivalents from common warrants

 

26

 

-

 

-

 

-

         

Weighted average shares outstanding—diluted

 

41,841

 

34,769

 

37,504

 

34,344

         

Income (loss) per share—basic

 

$ 0.79

 

$ (1.92)

 

$ (0.56)

 

$ (2.49)

         

Income (loss) per share—diluted

 

$ 0.73

 

$ (1.92)

 

$ (0.56)

 

$ (2.49)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
  

As of

 
  

September 30, 2023

  

September 30, 2022

 

Series B preferred (post split basis)

  -   127 

Common stock options and warrants

  3,281   5,064 

Debt with conversion feature at $30 per share of common stock

  1,259   1,256 

Total number of potentially dilutive shares

  4,540   6,447